TY - BOOK AU - Kvedaraite,Egle AU - Milne,Paul AU - Khalilnezhad,Ahad AU - Chevrier,Marion AU - Sethi,Raman AU - Lee,Hong Kai AU - Hagey,Daniel W. AU - von Bahr Greenwood,Tatiana AU - Mouratidou,Natalia AU - Jädersten,Martin AU - Lee,Nicole Yee Shin AU - Minnerup,Lara AU - Yingrou,Tan AU - Dutertre,Charles-Antoine AU - Benac,Nathan AU - Hwang,You Yi AU - Lum,Josephine AU - Loh,Amos Hong Pheng AU - Jansson,Jessica AU - Teng,Karen Wei Weng AU - Khalilnezhad,Shabnam AU - Weili,Xu AU - Resteu,Anastasia AU - Liang,Tey Hong AU - Guan,Ng Lai AU - Larbi,Anis AU - Howland,Shanshan Wu AU - Arnell,Henrik AU - Andaloussi,Samir EL AU - Braier,Jorge AU - Rassidakis,Georgios AU - Galluzzo,Laura AU - Dzionek,Andrzej AU - Henter,Jan-Inge AU - Chen,Jinmiao AU - Collin,Matthew AU - Ginhoux,Florent TI - NOTCH dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology PY - 2022///-12-23 KW - Text KW - local N1 - /pmc/articles/PMC7614120; /pubmed/36525505 N2 - Langerhans cell histiocytosis (LCH) is a potentially fatal neoplasm, characterized by the aberrant differentiation of mononuclear phagocytes, driven by mitogen-activated protein kinase pathway activation. LCH cells may trigger destructive pathology yet remain in precarious state, finely balanced between apoptosis and survival, supported by a unique inflammatory milieu. The interactions that maintain this state are not well-known and may offer targets for intervention. Here, we used single-cell RNA-seq and protein analysis to dissect LCH lesions, assessing LCH cell heterogeneity, and comparing LCH cells with normal MNPs within lesions. We found LCH-discriminatory signatures pointing to senescence and escape from tumor immune surveillance. We also uncovered two major lineages of LCH with DC2- and DC3/Monocyte-like phenotypes and validated them in multiple pathological tissue sites by high-content imaging. Receptor-ligand analyses and lineage tracing in vitro revealed Notch dependent cooperativity between DC2 and DC3/monocyte lineages, during expression of the pathognomonic LCH program. Our results present a convergent dual origin model of LCH with MAPK pathway activation occurring prior to fate commitment to DC2 and DC3/Monocyte lineages and Notch-dependent cooperativity between lineages driving the development of LCH cells UR - http://dx.doi.org/10.1126/sciimmunol.add3330 ER -